1 / 55

Pharmacokinetics -- part 1 --

Pharmacokinetics -- part 1 --. W.M. Tom Department of Pharmacology University of Hong Kong. Pharmacokinetics . -- refers to the action of the body on the drug, including: absorption distribution elimination -- metabolism & excretion. Drug Disposition. Drug Absorption .

inge
Télécharger la présentation

Pharmacokinetics -- part 1 --

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Pharmacokinetics-- part 1 -- W.M. Tom Department of Pharmacology University of Hong Kong

  2. Pharmacokinetics -- refers to the action of the body on the drug, including: absorption distribution elimination -- metabolism & excretion

  3. Drug Disposition

  4. Drug Absorption Peroral administration (P.O. route) swallowing commonly known as “oral administration” most convenient and economic method of systemic drug delivery dosage forms, e.g. tablets, capsules, syrups, etc.

  5. Drug absorption Solids are not absorbed! Dissolution is usually the rate limiting step!

  6. Drug Absorption Peroral administration (P.O. route) drug release  formulation (e.g. tablets)e.g. particle size, surface area, excipients (inert substances) DISINTEGRATION (solid )  DISSOLUTION (solution)  ABSORPTION  SYSTEMIC CIRCULATION (% bioavailability)

  7. Drug absorptionstomach (pH 1~3)in favour of weak acid absorptionduodenum (pH 5~7)in favour of weak base absorptionileum (pH 7~8)in favour of weak base absorption

  8. Diffusion Across Membrane (pH < pKa ) HA Weak Acid (pH > pKa ) A- (pH > pKa ) B Weak Base (pH < pKa ) BH+

  9. Drug Absorption Factors affecting drug absorption by enteral routes 1. Drug dissolution -- depends on drug formulation of oral preparations 2. pH environment in GI tract -- unionized form efficiently absorbed 3. Lipid solubility of the drug -- nonpolar form easily absorbed

  10. Drug Absorption Factors affecting drug absorption by enteral routes 4. Effects of food -- in general delays drug absorption 5. First pass effect -- absorption of a drug into the portal circulation -- drug metabolized by liver before it reaches the systemic circulation

  11. First-pass effectmouthesophagusstomachsmall intestinecolonrectum

  12. First - Pass Effect

  13. Drug Absorption Parenteral routes 1. intravenous injection (IV) -- directly into a vein -- 100% bioavailability 2. intramuscular injection (IM) -- into a muscle -- depends on blood supply

  14. Drug Absorption Parenteral routes 3. subcutaneous injection (SC) -- under the skin -- intended for slow absorption 4. others -- inhalation -- sublingual -- topical -- transdermal, etc.

  15. Absorption, distribution, metabolism and excretion

  16. Drug Distribution Drug transfer to various tissues -- depends on drug lipophilicity and blood flow Drug barriers -- e.g. blood-brain barrier, placenta Drug binding to plasma proteins -- bound drugs are pharmacologically inactive -- unbound drugs are free to distribute to target tissues -- different drugs may compete for binding to plasma proteins and displace each other from binding sites

  17. LOCUS OF ACTION “RECEPTORS” TISSUE RESERVOIRS Bound Free Free Bound ABSORPTION EXCRETION Free Drug SYSTEMIC CIRCULATION Bound Drug BIOTRANSFORMATION

  18. Saturation of Protein Binding Sites

  19. Drug displacement from protein binding sites

  20. Plasma Protein Binding consequence of drug displacement an increase in free drug concentration of the displaced drug  an increase in drug effect (be cautious when using a drug of low T.I.) a decrease in the duration of action of the displaced drug because more free drugs are available for elimination

  21. Drug Metabolism modification of the chemical structure by enzyme systems in the body -- e.g. cytochrome P450 in liver these chemical reactions produce water-soluble metabolites which are more readily excreted by the kidneys -- phase I reaction, e.g. oxidation -- phase II (conjugation) reaction, e.g. glucuronidation drug metabolism activity can be influenced by a variety of drugs

  22. The two phases of drug metabolism

  23. The two phases of drug metabolism

  24. Proportion of drugs metabolized by the major phase I and phase II enzymes

  25. Drug Metabolism enzyme induction -- results in faster rate of metabolism -- e.g. in heavy cigarette smokers, alcoholics enzyme inhibition -- results in slower rate of metabolism -- e.g. taking another drug which uses the same enzyme for metabolism biological variations in drug metabolism -- e.g. genetics, disease states, age, etc.

  26. Drug Excretion in urine -- by glomerular filtration and renal tubular secretion -- polar water-soluble metabolites readily excreted while nonpolar forms reabsorbed back to circulation in bile and feces other routes -- e.g. in sweat, milk and other body fluids -- volatile gases by exhalation

  27. Renal excretion of drugs-- lipid-soluble and un-ionized drugs are passively reabsorbed through the nephron-- active secretion of organic acids and bases occurs only in the proximal tubular segment-- in distal tubular segments, the secretion of H+ favours reabsorption of weak acids (less ionized) and excretion of weak bases (more ionized)

  28. Part 1 ended

  29. Pharmacokinetics-- part 2 -- W.M. Tom Department of Pharmacology University of Hong Kong

  30. Time course of action of a single oral dose Time of onset = T1 - T0Time to peak effect = T2 - T0Duration of action = T3 - T1MEC = minimum effective concentration

  31. Time course of drug action time of onset -- the time taken for the drug to produce a response time to peak effect -- the time taken for the drug to reach its highest blood concentration duration of action -- the time during which the drug produces a response elimination half-life ( t 1/2 ) -- the time taken to reduce the drug concentration in the blood by 50%

  32. One Compartment IV Bolus Pharmacokinetic Model Assumptions drug is mixed instantaneously in blood drug in the blood is in rapid equilibrium with drug in the extravascular tissues drug elimination follows first order kinetics

  33. One Compartment IV Bolus Pharmacokinetic Model rate of concentration change at each time point: dCp ——— = – k • Cp dt …. (1) Cp : plasma drug concnetration k : elimination rate constant

  34. One Compartment IV Bolus Pharmacokinetic Model Ct = C0 • e – k • t………. (2) Ct : plasma concentration at time t C0 : plasma concentration at time 0

  35. One Compartment IV Bolus Pharmacokinetic Model k • t log Ct = log C0 – ————— ………. (3) 2.303 Ct : plasma concentration at time t C0 : plasma concentration at time 0

  36. One Compartment IV Bolus Pharmacokinetic Model Apparent volume of distribution (Vd ) apparent volume that the drug is distributed into not a physiological volume amount of drug in the body X Vd = ———————————— = —— drug conc. In plasma Cp DOSE orVd = ————— ………………. (4) C0

  37. One Compartment IV Bolus Pharmacokinetic Model DOSE Vd = ————— ………………. (4) C0 substitute (4) to (3), I.e. Ct = C0 • e – k • t DOSE Ct = ————— • e– k • t………. (5) Vd

  38. One Compartment IV Bolus Pharmacokinetic Model Half-Life of Elimination ( t 1/2 ) time taken for the plasma concentration to fall to half its original value 0.693 t 1/2 = ————— ………………. (6) k

  39. One-compartment pharmacokinetics (single dose, IV)Cp = plasma drug concentration C0 = plasma concentration at time zerok el = elimination constant elimination half-life t 1/2 = t 2 - t 1

  40. One Compartment IV Bolus Pharmacokinetic Model Drug clearance ( CL ) a measure of he efficiency with which a drug is removed from the body rate of elimination amount of drug • k CL = ———————— = ————————— Cp Cp = Vd • k………………. (7) CL total = CL kidney + CL liver + CL others

  41. One Compartment IV Bolus Pharmacokinetic Model Bioavailability ( F ) measures the extent of absorption of a given drug, usually expressed as fraction of the administered dose intravenous injection, by definition, has a bioavailability of 100% AUC • CL F = —————————————— ….. (8) DOSE AUC : area under the conc.-time curve

  42. Bioavailability Plasma concentration (AUC)o (AUC)iv i.v. route oral route Time (hours)

  43. Multiple IV Bolus Dose Administration drug accumulation occurs when repeated doses are given before the drug is completely eliminated repeated drug administration at dose intervals (t ) will give a steady state with the plasma concentration fluctuating between a maximum (Cmax) and a minimum (Cmin ) value

  44. Plateau principleCss = steady state concentrationCmax = maximum CssCmin = minimum CssMEC = minimum effective concentrationMTC = minimum toxic concentrationtherapeutic range = MTC - MEC

  45. Time course of drug action plateau principle -- repeated drug administration at fixed dosage intervals will produce a plateau concentration of drug in the blood (I.e. steady state) steady state -- a state at which the rate of drug administration is equal to the rate of elimination therapeutic range -- the range between the minimum effective concentration (MEC) and the minimum toxic concentration (MTC) of a drug

  46. Effect of dosage intervals on drug concentration curve 1 -- dosage interval too short; curve 2 -- too long; curve 3 -- ideal

  47. Blood levels of drugs with intermittent dosage a typical oral dosage four times a day on a schedule of 10-2-6-10 or 9-1-5-9

More Related